MEDICAL POLYOXYMETHYLENE MARKET ANALYSIS
Global Medical Polyoxymethylene (POM) Market: Key Developments
In October 2018, KOLON BASF innoPOM started the commercial production of polyoxymethylene (POM) in Korea worth US$ 220 million. This was expected to add a capacity of 70,000 metric ton per year to BASF’s production line.
In June 2019, Celanese Corporation announced about increasing the prices of its Amcel and Celcon polyacetal (POM) grades and other functionalized grades.
In October 2018, Celanese Corporation was planning to increase the polyacetal production by 20,000 tons, at the Frankfurt facility, which is expected to be completed in next 18 to 24 months.
In January 2019, Polyplastics Group announced the development of the Duracon polyoxymethylene (POM) PM series for drug contact and delivery applications for the medical/healthcare market.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
